⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TEVA News
Teva Pharmaceutical Industries Limited American Depositary Shares
2026 Complement Inhibitors Market Analysis Report (2nd Edition) Featuring Amgen, CSL Behring, Innovent Biologics, Novartis, Regeneron, Roche, Sanofi, Takeda, UCB
globenewswire.com
AMGN
CSL
NVS
REGN
SNY
UCB
AZN
IONS
TEVA
Teva Announces Positive Topline Results from Phase 2a Study in Celiac Disease for Its Anti-IL-15 Antibody, Further Validating Its Pipeline-in-a-Product Potential
globenewswire.com
TEVA
$CAPR News: Capricor Therapeutics Sued for Securities Fraud Over Alleged Misrepresentations about its Clinical Data – Contact BFA Law by September 28 if You Lost Money
globenewswire.com
CAPR
TSLA
TEVA
Teva to Present at Morgan Stanley, J.P. Morgan and BofA Investor Conferences in September
globenewswire.com
TEVA
Global Anti-Obesity Drugs Market Report 2026: Set to Reach $106.5 Billion by 2035 as GLP-1 Therapies Transform Obesity Care
globenewswire.com
OPK
NVO
LLY
TEVA
DKS Investigation Alert: Dick's Sporting Goods Inventory Issues and Subsequent 30% Stock Drop Lead to Investor Securities Fraud Investigation to Recover Losses
prnewswire.com
DKS
TSLA
TEVA
RXT Class Action Alert: Rackspace Technology AI Effort Issues and Subsequent 33% Stock Drop Lead to Investor Securities Fraud Class Action to Recover Losses
prnewswire.com
RXT
AMD
TSLA
TEVA
CCB Investment Losses: Coastal Financial Banking Services Issues Lead to 43% Stock Drop – BFA Law Reminds Investors of the Pending Securities Fraud Investigation
globenewswire.com
CCB
TSLA
TEVA
RXT Investment Losses: Rackspace Technology AI Effort Issues Lead to 33% Stock Drop – BFA Law Reminds Investors of the Pending Securities Fraud Class Action
globenewswire.com
RXT
AMD
TSLA
TEVA
Alvotech announces FDA acceptance for review of Biologics License Application for AVT80, expanding proposed biosimilar program for Entyvio® to subcutaneous presentations
globenewswire.com
ALVO
TEVA